DHR
Not a breakup note — more like a haircut
Barclays took scissors to Danaher’s price target, trimming it to $230 from $250, but didn’t touch the Overweight rating. Translation: the bank still thinks Danaher deserves a seat at the grown-ups’ table, just not quite as much confetti as before.
What this means for your portfolio
This kind of move is less “we’re out” and more “the vibe got a little less sparkling.” When analysts cut targets but keep ratings intact, they’re usually adjusting expectations, not torching the thesis. For Danaher, that can still matter because the stock had already been getting a lot of analyst attention — and when everyone’s nudging targets lower around the same time, investors start wondering if the market was a little too rosy.
The Street is clearly re-pricing the story
Barclays’ call lands right after a few other firms also trimmed their Danaher targets this month. So this isn’t one lonely analyst having a mood swing — it’s more like the whole desk deciding the company deserves a slightly smaller trophy.
- Barclays: $230 target, Overweight
- TD Cowen: $245 target, Buy
- Goldman Sachs: $230 target, Buy
- Evercore ISI: $225 target, Outperform
Big picture
For investors, the key question isn’t whether Danaher is still liked — it clearly is. It’s whether the stock has already priced in too much good news. Today’s cut says the ceiling may be a little lower than the Street used to think, but the floor still looks sturdier than a lot of other names in the market.